sotagliflozin 400 MG Oral Tablet

RxCUI: 2638691
RxNorm name: sotagliflozin 400 MG Oral Tablet
Display name: sotagliflozin 400 MG Oral Tablet
Full name: sotagliflozin 400 MG Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
INPEFA	SOTAGLIFLOZIN	Lexicon Pharmaceuticals, Inc.	1a46614e-05f6-421a-b6f4-d6f8760d643a	2026-01-29	Warnings, Adverse reactions	Exact identifier rxcui: 2638691

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
1a46614e-05f6-421a-b6f4-d6f8760d643a	sotagliflozin 400 MG Oral Tablet	SCD	10	These highlights do not include all the information needed to use INPEFA safely and effectively. See full prescribing information for INPEFA. INPEFA ® (sotagliflozin) tablets, for oral use Initial U.S. Approval: 2023	20260129
1a46614e-05f6-421a-b6f4-d6f8760d643a	sotagliflozin 400 MG Oral Tablet	PSN	10	These highlights do not include all the information needed to use INPEFA safely and effectively. See full prescribing information for INPEFA. INPEFA ® (sotagliflozin) tablets, for oral use Initial U.S. Approval: 2023	20260129